🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open label phase II clinical trial to determine the efficacy, to...
Status
Completed
Location
Houston Methodist Hospital
Start Date
2017-04-24
Trial ID
NCT02988986
This phase I trial studies the side effects and best dose of sapanisertib w...
Status
Active Not Recruiting
Location
Smilow Cancer Center/Yale-New Haven Hospital
Start Date
2017-03-23
Trial ID
NCT02503722
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-03
Trial ID
NCT03205891
Treatments Being Tested
The primary purpose of this study is to determine if sapanisertib in combin...
Status
Completed
Location
University of Alabama Comprehensive Cancer Center
Start Date
2016-04-01
Trial ID
NCT02725268
Treatments Being Tested
This phase I trial studies the side effects and best dose of sapanisertib a...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2014-06-18
Trial ID
NCT02159989
Treatments Being Tested
This phase II trial studies how well sapanisertib works in treating patient...
Status
Completed
Location
Memorial Sloan Kettering Basking Ridge
Start Date
2016-10-06
Trial ID
NCT02417701
Treatments Being Tested
This study evaluates efficacy of TAK- 228 and TAK- 117 followed by cisplati...
Status
Completed
Location
Baylor University Medical Center
Start Date
2017-07-18
Trial ID
NCT03193853
Treatments Being Tested
Millennium has developed TAK-228, which is a novel, highly selective, orall...
Status
Withdrawn
Location
Dartmouth Hitchcock Medical Center
Start Date
2017-04-20
Trial ID
NCT02619669
This research study is investigating a drug as a possible treatment for met...
Status
Completed
Location
University of California, San Diego Moores Cancer Center
Start Date
2017-08-01
Trial ID
NCT03097328
Treatments Being Tested
This phase II LUNG-MAP treatment trial studies how well sapanisertib and do...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-09-05
Trial ID
NCT04267913
Treatments Being Tested